JERUSALEM--(BUSINESS WIRE)--BioJerusalem, an initiative of the Jerusalem Development Authority (JDA), announced today the launch of its activities. JDA has allocated 10 million NIS that will be directly invested in developing the life science industry in Jerusalem through BioJerusalem. This amount will be supplemented by additional funds that will serve to advance the biomedical industry in the city and create new job opportunities. These funds stem from the Jerusalem Economic Development Program approved by the Israeli government in 2005, which originally allocated 280 million NIS, to be distributed over seven years, for the economic development of the city.
